Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering
This study has been completed.
Study NCT00830154   Information provided by Endo Pharmaceuticals

First Received on January 25, 2009.   Last Updated on August 20, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Stuttering
More general conditions related to this trial
Communication Disorders
Language Disorders
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Signs and Symptoms
Speech Disorders
Interventions listed in this trial
pagoclone
placebo
Sponsors listed in this trial
Endo Pharmaceuticals
Teva Pharmaceuticals USA


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services